<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00721175</url>
  </required_header>
  <id_info>
    <org_study_id>HE500636</org_study_id>
    <nct_id>NCT00721175</nct_id>
  </id_info>
  <brief_title>Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma</brief_title>
  <official_title>Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Unresectable Complex Hilar Cholangiocarcinoma; a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Khon Kaen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the adequacy of unilateral endoscopic biliary
      drainage using metallic stent with plastic stent in unresectable, complex, hilar,
      cholangiocarcinoma and cost analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are two types of biliary stents: 1) the plastic stent made from polyethylene or
      polytetrafluoroethylene; and, 2) the metal stent braided in the form of a tubular mesh from
      surgical-grade stainless steel alloy and designed to expand to a maximum diameter of 10 mm.
      The main drawback of the plastic stent is the relatively high occlusion rate, but its
      advantage is the lower cost. The use of a metal stent for hilar tumor has many theoretical
      advantages: 1) the flexible open-mesh design should allow drainage of secondary duct
      branches; and, 2) its larger diameter may provide better drainage and longer patency (~3-9
      months).

      Whether one type of stent is superior in terms of adequacy of drainage or cost-effectiveness
      remains undefined. Therefore, we would conduct this study to assess the efficacy of drainage
      of endoscopically-inserted, unilateral, plastic stents vs. metallic stents in unresectable,
      complex, hilar cholangiocarcinoma patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(ITT Analysis)</measure>
    <time_frame>at 2 weeks and 4 weeks after stent insertion</time_frame>
    <description>Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively in each patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(Per Protocol Analysis)</measure>
    <time_frame>at 2 weeks and 4 weeks after stent insertion</time_frame>
    <description>Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients Survival Times</measure>
    <time_frame>until patient died or 6 months after the last patient was enrolled</time_frame>
    <description>survival times of the patients after the first stent insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost Effective Ratio of Metallic and Plastic Stent</measure>
    <time_frame>until the patients expire (Markov model)</time_frame>
    <description>cost per quality adjusted life year (QALY)of metallic stent and plastic stent calculated from Markov model using transitional probabilities, cost and utilities from this study and the available literature</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Hilar Cholangiocarcinoma</condition>
  <arm_group>
    <arm_group_label>SEMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>self-expandable metal stent group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>plastic stent group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>biliary stent (self expandable metallic stent)</intervention_name>
    <description>metallic stent was inserted into right or left hepatic duct which was planed before intervention using CT scan or MRCP</description>
    <arm_group_label>SEMS</arm_group_label>
    <other_name>self expandable metallic stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PS</intervention_name>
    <description>plastic stent was inserted into right or left hepatic duct which was planed before intervention using CT scan or MRCP</description>
    <arm_group_label>PS</arm_group_label>
    <other_name>Amsterdam type plastic stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unresectable complex hilar cholangiocarcinoma which diagnosis and staging based on
             computed tomography(CT) or magnetic resonance cholangiopancreatography (MRCP)

        Exclusion Criteria:

          -  Patients with ASA 4 or 5

          -  Patients with liver failure.

          -  Patients unable to comply with follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>apichat sangchan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine. Faculty of Medicine. KhonKaen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Srinagarind Hospital. KhonKaen University.</name>
      <address>
        <city>Muang</city>
        <state>KhonKaen</state>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://eckku.kku.ac.th/</url>
    <description>KhonKaen University Ethics Committee for Human Research</description>
  </link>
  <reference>
    <citation>De Palma GD, Pezzullo A, Rega M, Persico M, Patrone F, Mastantuono L, Persico G. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc. 2003 Jul;58(1):50-3.</citation>
    <PMID>12838220</PMID>
  </reference>
  <reference>
    <citation>Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993 Mar;25(3):213-8.</citation>
    <PMID>7686100</PMID>
  </reference>
  <reference>
    <citation>Freeman ML, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc. 2003 Jul;58(1):41-9.</citation>
    <PMID>12838219</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2008</study_first_submitted>
  <study_first_submitted_qc>July 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2008</study_first_posted>
  <results_first_submitted>August 23, 2011</results_first_submitted>
  <results_first_submitted_qc>November 21, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 23, 2011</results_first_posted>
  <last_update_submitted>November 21, 2011</last_update_submitted>
  <last_update_submitted_qc>November 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Apichat Sangchan</investigator_full_name>
    <investigator_title>Assist. Prof.</investigator_title>
  </responsible_party>
  <keyword>biliary stent</keyword>
  <keyword>plastic stent</keyword>
  <keyword>metallic stent</keyword>
  <keyword>Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Klatskin Tumor</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between November 2007 and March 2010, one hundred and eight patients who visited medical clinic at Srinagarind hospital, Khon Kaen University were randomized into the study</recruitment_details>
      <pre_assignment_details>the patients were excluded from trial after enrollment if CBD canulation is failed.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>SEMS</title>
          <description>self-expandable metal stent group</description>
        </group>
        <group group_id="P2">
          <title>Plastic Stent</title>
          <description>plastic stent group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SEMS</title>
          <description>self-expandable metal stent group</description>
        </group>
        <group group_id="B2">
          <title>Plastic Stent</title>
          <description>plastic stent group</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="54"/>
            <count group_id="B2" value="54"/>
            <count group_id="B3" value="108"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.7" spread="10.3"/>
                    <measurement group_id="B2" value="57.3" spread="11.7"/>
                    <measurement group_id="B3" value="60.0" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Thailand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(ITT Analysis)</title>
        <description>Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively in each patient.</description>
        <time_frame>at 2 weeks and 4 weeks after stent insertion</time_frame>
        <population>All 108 participants enrolled into the study were analyzed based on ITT analysis basis.(54 participants in each group)</population>
        <group_list>
          <group group_id="O1">
            <title>SEMS</title>
            <description>SEMS (Self-expandable metal stent group)</description>
          </group>
          <group group_id="O2">
            <title>Plastic Stent</title>
            <description>Plastic stent group</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(ITT Analysis)</title>
          <description>Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively in each patient.</description>
          <population>All 108 participants enrolled into the study were analyzed based on ITT analysis basis.(54 participants in each group)</population>
          <units>proportion of participants</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".7037037" lower_limit=".5819144" upper_limit=".825493"/>
                    <measurement group_id="O2" value=".46296" lower_limit=".3299707" upper_limit=".5959553"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.011</p_value>
            <method>Two-sample test of proportion</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-.2407407</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>.0920078</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-.4210726</ci_lower_limit>
            <ci_upper_limit>-.0604089</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients Survival Times</title>
        <description>survival times of the patients after the first stent insertion</description>
        <time_frame>until patient died or 6 months after the last patient was enrolled</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SEMS</title>
            <description>SEMS (Self-expandable metal stent group)</description>
          </group>
          <group group_id="O2">
            <title>Plastic Stent</title>
            <description>Plastic stent group</description>
          </group>
        </group_list>
        <measure>
          <title>Patients Survival Times</title>
          <description>survival times of the patients after the first stent insertion</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126" lower_limit="42" upper_limit="290"/>
                    <measurement group_id="O2" value="49" lower_limit="21" upper_limit="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0021</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost Effective Ratio of Metallic and Plastic Stent</title>
        <description>cost per quality adjusted life year (QALY)of metallic stent and plastic stent calculated from Markov model using transitional probabilities, cost and utilities from this study and the available literature</description>
        <time_frame>until the patients expire (Markov model)</time_frame>
        <population>Simulation cohort of any number of the patients (1, 100 or 1,000 patients) enter the Markov model using transitional probabilities, cost data, utility data from this study and available literature to calculate the cost effectiveness ratio of metallic stent and plastic stent in unresectable complex hilar cholangiocarcinoma</population>
        <group_list>
          <group group_id="O1">
            <title>SEMS</title>
            <description>SEMS (Self-expandable metal stent group)</description>
          </group>
          <group group_id="O2">
            <title>Plastic Stent</title>
            <description>Plastic stent group</description>
          </group>
        </group_list>
        <measure>
          <title>Cost Effective Ratio of Metallic and Plastic Stent</title>
          <description>cost per quality adjusted life year (QALY)of metallic stent and plastic stent calculated from Markov model using transitional probabilities, cost and utilities from this study and the available literature</description>
          <population>Simulation cohort of any number of the patients (1, 100 or 1,000 patients) enter the Markov model using transitional probabilities, cost data, utility data from this study and available literature to calculate the cost effectiveness ratio of metallic stent and plastic stent in unresectable complex hilar cholangiocarcinoma</population>
          <units>cost (US$) per QALY</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10742"/>
                    <measurement group_id="O2" value="19085"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(Per Protocol Analysis)</title>
        <description>Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively.</description>
        <time_frame>at 2 weeks and 4 weeks after stent insertion</time_frame>
        <population>91 participants who had successful stent insertion were analyzed based on per protocol analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>SEMS</title>
            <description>SEMS (Self-expandable metal stent group)</description>
          </group>
          <group group_id="O2">
            <title>Plastic Stent</title>
            <description>Plastic stent group</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Patients With Adequate Biliary Drainage in Metallic Stent and Plastic Stent Group.(Per Protocol Analysis)</title>
          <description>Successful drainage was defined as a decrease in total bilirubin level to less than 30% or 50% of pretreatment level within two and four weeks respectively.</description>
          <population>91 participants who had successful stent insertion were analyzed based on per protocol analysis.</population>
          <units>proportion of participants</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.822" lower_limit="0.711" upper_limit="0.934"/>
                    <measurement group_id="O2" value="0.543" lower_limit="0.400" upper_limit="0.687"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <method>Two-sample test of proportion</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-.278744</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>.0929622</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-.4609466</ci_lower_limit>
            <ci_upper_limit>-.0965414</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SEMS</title>
          <description>self-expandable metal stent group</description>
        </group>
        <group group_id="E2">
          <title>Plastic Stent</title>
          <description>plastic stent group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>cholangitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="54"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>sphicterotomy bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Assist. Prof. Apichat Sangchan</name_or_title>
      <organization>Khon Kaen University</organization>
      <phone>66850004651</phone>
      <email>apichaz@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

